Last update : 07/08/2014 | Version : 1 | ID : 60011
General | |
Identification | |
Detailed name | Familial Retinal Vein Occlusion |
Sign or acronym | OVR |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | banque d'ADN de l'institut de la vision |
General Aspects | |
Medical area |
Cardiology Ophthalmology |
Health determinants |
Genetic Occupation |
Others (details) | Familial retinal vein occlusion |
Keywords | urban population, Health episodes, rural population, hospitalisation, health system |
Scientific investigator(s) (Contact) | |
Name of the director | Paques |
Surname | Michel |
Address | 75012 PARIS |
Phone | + 33 (0)1 40 02 14 54 |
michel.paques@gmail.com | |
Unit | CIC 503 INSERM |
Organization | INSERM - Institut National de la Santé et de la Recherche |
Collaborations | |
Funding | |
Funding status |
Public |
Details | PHRC |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | INSERM - Institut National de la Santé et de la Recherche Médicale |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
Database recruitment is carried out by an intermediary |
An administrative base or a register |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Retrospective Number of required subjects: [100-500] |
Database objective | |
Main objective | General objective: to phenotype forms of familial retinal vein occlusion Secondary objective: to collect DNA |
Inclusion criteria | At least 3 cases of retinal vein occlusion (RVO) in the immediate family (two cases if one occurs before the age of 30). |
Population type | |
Age |
Great age (80 years and more) |
Population covered |
General population |
Gender |
Male Woman |
Geography area |
Local |
Detail of the geography area | Multicentric cohort throughout France (2 centres) |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 01/2000 |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Details of the number of individuals | 40 (03/05/2013) |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Declarative data Paraclinical data Biological data |
Clinical data (detail) |
Direct physical measures Medical registration |
Declarative data (detail) |
Face to face interview |
Paraclinical data (detail) | Imaging |
Biological data (detail) | Type of samples taken: DNA |
Presence of a biobank |
Yes |
Contents of biobank |
DNA |
Details of biobank content | DNA bank |
Health parameters studied |
Health event/morbidity Health event/mortality |
Procedures | |
Data collection method | Self-administered questionnaire: input from a paper questionnaire; Interviews: direct input; Clinical examinations: handwritten Biological analysis: handwritten |
Participant monitoring |
No |
Details on monitoring of participants | (Indefinite duration) |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/17173011 |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/20703046 |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/19701812 |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | To be decided if data may be used by academic teams To be decided if data may be used by industrial teams |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05